Home/Pipeline/BEAT‑CAR‑T-001

BEAT‑CAR‑T-001

Solid Tumours (breast, colon, pancreas, prostate)

PreclinicalActive

Key Facts

Indication
Solid Tumours (breast, colon, pancreas, prostate)
Phase
Preclinical
Status
Active
Company

About Currus Biologics

Australian biotech using a bispecific engager platform to unlock CAR‑T efficacy against solid tumours.

View full company profile

Therapeutic Areas